TSX-V:IBO
Addiction
Ibogaine
About Us
Investor
News
Media
Contact
Press & News
We are on a journey to addiction free living and every step counts.
Stay up to date with the latest news and info on our growth.
May 12, 2022
Universal Ibogaine Advises Of Departure Of Marilyn Mauritz From Board Of Directors
Read More
May 12, 2022
Universal Ibogaine Provides Update On Kelburn Recovery Center Operations
Read More
April 5, 2022
Universal Ibogaine Announces Frankfurt Stock Exchange Listing
Read More
March 24, 2022
Universal Ibogaine To Participate In The 2022 Virtual Growth Conference
Read More
March 23, 2022
Universal Ibogaine Expands Research Team With Julie Dumouchel, Director Of Clinical Trials
Read More
March 8, 2022
Universal Ibogaine To Present At Otc Virtual Investor Event
Read More
February 28, 2022
Universal Ibogaine Announces Approval Of Trading On Otcqb Venture Market
Read More
February 10, 2022
Universal Ibogaine Signs Memorandum Of Understanding With Osoyoos Indian Band
Read More
February 2, 2022
Universal Ibogaine Commences Development Plan At Kelburn In Preparation For Ibogaine Treatments And Provides Update On Drug Supply
Read More
January 26, 2022
Universal Ibogaine Enters Drug Supply Agreement
Read More
January 14, 2022
Universal Ibogaine Announces World-class Clinical Trial Partners In Advance Of Clinical Trial Application For Ibogaine In Opioid Use Disorder
Read More
January 10, 2022
Universal Ibogaine Announces Change In Leadership
Read More
December 22, 2021
Universal Ibogaine Announces Expansion Of Executive Team And Grant Of Stock Options
Read More
November 4, 2021
Universal Ibogaine Announces Chief Clinics Officer Dr Ian Rabb
Read More
November 4, 2021
Universal Ibogaine Announces Engagement Of Media And Investor Relations Advisors
Read More
November 4, 2021
Universal Ibogaine Announces Engagement Of Investor Relations Advisor
Read More
October 19, 2021
Universal Ibogaine Announces Enhancements To Board Of Directors
Read More
October 5, 2021
Universal Ibogaine Commences Trading On The Tsx-v
Read More
October 5, 2021
Universal Ibogaine Announces Extension Of Convertible Notes Payable And Engagement Of Market Maker Firms
Read More
October 1, 2021
Universal Ibogaine Inc. Announces Tsx-v Final Approval Of Qt, Resumption Of Trading Date And Clarification Of Certain Filing Statement Disclosures
Read More
September 2, 2021
P Squared Renewables Inc. Announces The Completion Of Qualifying Transaction And The Prior Closing Of $6 Million Subscription Receipt Financing
Read More
September 2, 2021
P Squared Renewables Inc. And Universal Ibogaine Inc. Announce Filing Of Filing Statement On Sedar
Read More
July 23, 2021
P Squared Renewables Inc. And Universal Ibogaine Inc. Announce Tsx.v Conditional Approval Of Qualifying Transaction
Read More
July 5, 2021
P Squared Renewables Inc. Provides Update On Con-current Financing And Qt And Announces Changes To Board Of Directors
Read More
June 4, 2021
Psquared Renewables Inc And Universal Ibogaine Inc. Engage Boustead Securities, Llc To Participate In Go-public Financing
Read More
March 30, 2021
P Squared Renewables Inc. Announces Engagement Of Sponsor And Provides Update On Qualifying Transaction With Universal Ibogaine Inc.
Read More
February 25, 2021
Psychedelic Summit
Read More
February 23, 2021
Universal Ibogaine Engages Dr Rami Batal As Chief Executive Officer
Read More
February 19, 2021
Ibogaine Masterclass
Read More
January 10, 2021
Universal Ibogaine Engages The Conscious Fund For Corporate Advisory Services
Read More
November 25, 2020
Universal Ibogaine Inc. Announces Initial Closing Of Private Placement Financing
Read More
October 15, 2020
P Squared Renewables – October 2020 Letter To Shareholders
Read More
October 15, 2020
Universal Ibogaine Retains Westmount Park Investments For Corporate Financial Advisory Services
Read More